Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old With Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial.
Norén-Nyström U, Andersen MK, Barbany G, Dirse V, Eilert-Olsen M, Engvall M, Harila-Saari A, Heyman M, Hovland R, Häikiö S, Jónsson JJ, Karhu R, Kjeldsen E, Norberg A, Preiss BS, Pulkkinen K, Quist-Paulsen P, Räsänen H, Schmiegelow K, Seitsonen A, Sjögren H, Tammur P, Johansson B. Norén-Nyström U, et al. Among authors: schmiegelow k. Hemasphere. 2023 May 4;7(5):e883. doi: 10.1097/HS9.0000000000000883. eCollection 2023 May. Hemasphere. 2023. PMID: 37153872 Free PMC article. No abstract available.
The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia.
Østergaard A, Enshaei A, Pieters R, Vora A, Horstmann MA, Escherich G, Johansson B, Heyman M, Schmiegelow K, Hoogerbrugge PM, den Boer ML, Kuiper RP, Moorman AV, Boer JM, van Leeuwen FN. Østergaard A, et al. Among authors: schmiegelow k. Hemasphere. 2023 May 4;7(5):e875. doi: 10.1097/HS9.0000000000000875. eCollection 2023 May. Hemasphere. 2023. PMID: 37153875 Free PMC article.
Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling.
Mosquera Orgueira A, Krali O, Pérez Míguez C, Peleteiro Raíndo A, Díaz Arias JÁ, González Pérez MS, Pérez Encinas MM, Fernández Sanmartín M, Sinnet D, Heyman M, Lönnerholm G, Norén-Nyström U, Schmiegelow K, Nordlund J. Mosquera Orgueira A, et al. Among authors: schmiegelow k. Clin Epigenetics. 2024 Mar 28;16(1):49. doi: 10.1186/s13148-024-01662-6. Clin Epigenetics. 2024. PMID: 38549146 Free PMC article.
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
Schmiegelow K, Al-Modhwahi I, Andersen MK, Behrendtz M, Forestier E, Hasle H, Heyman M, Kristinsson J, Nersting J, Nygaard R, Svendsen AL, Vettenranta K, Weinshilboum R; Nordic Society for Paediatric Haematology and Oncology. Schmiegelow K, et al. Blood. 2009 Jun 11;113(24):6077-84. doi: 10.1182/blood-2008-11-187880. Epub 2009 Feb 17. Blood. 2009. PMID: 19224761 Free PMC article.
DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia: is there a causal relationship?
Harju T, Hurme-Niiranen A, Suo-Palosaari M, Nygaard Nielsen S, Hinttala R, Schmiegelow K, Uusimaa J, Harila A, Niinimäki R. Harju T, et al. Among authors: schmiegelow k. Pharmacogenomics J. 2023 Sep;23(5):105-111. doi: 10.1038/s41397-023-00303-0. Epub 2023 May 3. Pharmacogenomics J. 2023. PMID: 37138020 Free PMC article.
Therapeutic drug monitoring of imatinib - how far are we in the leukemia setting?
Buhl Rasmussen AS, Andersen CL, Weimann A, Yang T, Tron C, Gandemer V, Dalhoff K, Rank CU, Schmiegelow K. Buhl Rasmussen AS, et al. Among authors: schmiegelow k. Expert Rev Clin Pharmacol. 2024 Mar;17(3):225-234. doi: 10.1080/17512433.2024.2312256. Epub 2024 Feb 12. Expert Rev Clin Pharmacol. 2024. PMID: 38345044 Review.
537 results